Eye-tracking test for Parkinson's given FDA Breakthrough Device status

The US Food and Drug Administration (FDA) has delivered a Breakthrough Device Designation to a novel eye-tracking technology that claims to offer objective and early diagnosis of Parkinson's disease. The FDA designation is hoped to accelerate the"...